Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Content Type

Events

Resource Hubs

Harry Suryapranata

Department of Cardiology, Radboud University Medical Centre, Nijmegen, the Netherlands

Expertise

Intervention Coronary Interventions Anticoagulation Antiplatelet MI/ACS Unstable Angina & NSTEMI STEMI

Articles by Harry Suryapranata

Are There Differences in the Demographics and Clinical Outcomes Between Asian and European Patients Treated With the COMBO Dual Therapy Stent in the REDUCE Trial Populations?

Wan Azman Wan Ahmad, Edouard Benit, Cyril Camaro, et al

Published: 13 October 2022

Citation: Journal of Asian Pacific Society of Cardiology 2022;1:e25.

DOI:

https://doi.org/10.15420/japsc.2022.02

Dual Antiplatelet Therapy for 3 or 12 Months in Patients with Non-ST-elevation MI/ Unstable Angina or ST-elevation MI: Analysis of the REDUCE Trial

Wan Azman Wan Ahmad, Edouard Benit, Victor M Legrand, et al

Published: 29 July 2022

Citation: Journal of Asian Pacific Society of Cardiology 2022;1:e18.

DOI:

https://doi.org/10.15420/japsc.2021.29